NYSEAMERICAN:AZTR Azitra (AZTR) Stock Price, News & Analysis → Tech GIANT’s Plans to Revolutionize Crypto… (From Crypto 101 Media) (Ad) Free AZTR Stock Alerts $0.26 0.00 (0.00%) (As of 05/8/2024 ET) Add Compare Share Share Today's Range$0.24▼$0.2950-Day Range N/A52-Week Range$0.16▼$5.18Volume3.88 million shsAverage Volume618,575 shsMarket Capitalization$7.49 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartEarningsHeadlinesInsider TradesOwnershipShort InterestStock AnalysisChartEarningsHeadlinesInsider TradesOwnershipShort Interest Get Azitra alerts: Email Address Ad Crypto Swap ProfitsHe Is Giving Away BitcoinAnd my special guest is willing to give you $10 in Bitcoin (BTC) if you take it seriously. Right now is a very important time to pay attention to what we are doing and what is happening. If you wait... it will be too late. This week we are holding several workshops and if you attend and pay attention my special guest is going to send you $10 in Bitcoin.>> Register right here About Azitra Stock (NYSEAMERICAN:AZTR)Azitra, Inc., an early-stage biopharmaceutical company, develops therapies for precision dermatology using engineered proteins and live biotherapeutic products to treat skin diseases. It develops ATR-12, a genetically modified strain of S. epidermidis, which is in Phase Ib clinical trial for treating Netherton syndrome, a skin disease. The company also develops ATR-04, a genetically modified strain of S. epidermidis for treating the papulopustular rash experienced by cancer patients undergoing epidermal growth factor receptor inhibitor; and ATR-01, an engineered recombinant human filaggrin protein for treating ichthyosis vulgaris, a skin disease. It has a collaboration with Bayer. The company was incorporated in 2014 and is based in Branford, Connecticut.Read More AZTR Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart AZTR Stock News HeadlinesApril 22, 2024 | businesswire.comAzitra, Inc. Announces New Preclinical Data to be Presented at the American Society of Gene and Cell Therapy MeetingApril 18, 2024 | businesswire.comAzitra, Inc. to Present New Data at Three Upcoming Scientific Conferences in May 2024May 9, 2024 | Priority Gold (Ad)The 2024 Gold Rush: Unleashing Market PotentialWelcome to the financial rollercoaster of 2024, where inflation is persistent, stock markets are overinflated and volatile, global conflicts are intensifying, and the national debt is reaching new heights.April 2, 2024 | finance.yahoo.comInsiders Are Buying These 11 Penny StocksApril 2, 2024 | benzinga.comSilo Pharma And 3 Other Stocks Under $5 Insiders Are BuyingMarch 15, 2024 | businesswire.comAzitra, Inc. Announces Full Year 2023 Financial Results and Provides Business UpdatesFebruary 16, 2024 | finance.yahoo.comAzitra, Inc. Announces Closing of Public OfferingFebruary 16, 2024 | businesswire.comAzitra, Inc. Announces Closing of Public OfferingMay 9, 2024 | Priority Gold (Ad)The 2024 Gold Rush: Unleashing Market PotentialWelcome to the financial rollercoaster of 2024, where inflation is persistent, stock markets are overinflated and volatile, global conflicts are intensifying, and the national debt is reaching new heights.February 14, 2024 | benzinga.comDow Edges Higher; QuidelOrtho Shares PlummetFebruary 14, 2024 | benzinga.comNasdaq Gains 100 Points; Kraft Heinz Sales Miss ViewsFebruary 14, 2024 | nasdaq.comAzitra Prices Underwritten Public Offering Of 16.67 Mln Shares At $0.30/shr; Stock DropsFebruary 14, 2024 | msn.comWhy Azitra (AZTR) Shares Are Down 67%February 14, 2024 | investorplace.comWhy Is Azitra (AZTR) Stock Down 70% Today?February 14, 2024 | investorplace.comWhy Is Azitra (AZTR) Stock Down 70% Today?February 14, 2024 | finance.yahoo.comAzitra, Inc. Announces Pricing of Public OfferingFebruary 13, 2024 | businesswire.comAzitra, Inc. Announces Pricing of Public OfferingJanuary 19, 2024 | benzinga.comS&P 500 Gains 1%; State Street Reports Upbeat EarningsJanuary 17, 2024 | msn.comABAT, PRQR and SHOT among mid-day moversJanuary 16, 2024 | finance.yahoo.comAzitra, Inc. Strengthens Intellectual Property Portfolio with Newly Granted Patent in the USNovember 15, 2023 | msn.comAzitra GAAP EPS of -$0.16, revenue of $0.31MNovember 14, 2023 | finance.yahoo.comAzitra, Inc. Announces Third Quarter 2023 Financial Results and Business UpdatesOctober 16, 2023 | finance.yahoo.comAzitra to Present at the ThinkEquity ConferenceAugust 29, 2023 | finance.yahoo.comAzitra to Present at the H.C. Wainwright 25th Annual Global Investment ConferenceAugust 14, 2023 | finance.yahoo.comAzitra, Inc. Announces Second Quarter 2023 Financial Results and Business UpdatesJuly 19, 2023 | finance.yahoo.comAzitra Adds Biotech Leaders Barbara Ryan and John Schroer to Its Board of DirectorsJuly 11, 2023 | markets.businessinsider.comAzitra Names Travis Whitfill COOSee More Headlines Receive AZTR Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Azitra and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Today5/08/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNYSEAMERICAN SectorMedical Industry Pharmaceutical preparations Sub-IndustryN/A Current SymbolNYSEAMERICAN:AZTR CUSIPN/A CIKN/A Webazitrainc.com Phone203-646-6446FaxN/AEmployees10Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity Ratio0.01 Current Ratio1.58 Quick Ratio1.58 Sales & Book Value Annual Sales$690,000.00 Price / Sales10.86 Cash FlowN/A Price / Cash FlowN/A Book Value$0.24 per share Price / Book1.08Miscellaneous Outstanding Shares28,810,000Free FloatN/AMarket Cap$7.49 million OptionableNot Optionable BetaN/A 10 "Recession Proof" Stocks That Will Thrive in Any MarketWhich stocks are likely to thrive in today's challenging market? Click the link below and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.Get This Free Report Key ExecutivesMr. Francisco D. Salva (Age 53)President, CEO & Director Comp: $427.03kMr. Travis M. Whitfill M.P.H. (Age 34)Ph.D., Co-Founder, COO & Director Comp: $161.61kMr. Norman Staskey (Age 54)CFO, Treasurer & Secretary Comp: $314.02kDr. Mark SampsonChief Scientific OfficerKey CompetitorsAinosNASDAQ:AIMDKinetaNASDAQ:KATFF PharmaceuticalsNASDAQ:TFFPProcessa PharmaceuticalsNASDAQ:PCSAEmmaus Life SciencesOTCMKTS:EMMAView All CompetitorsInsidersNorm StaskeyBought 47,600 shares on 3/29/2024Total: $9,996.00 ($0.21/share)Francisco D SalvaBought 333,300 shares on 2/13/2024Total: $99,990.00 ($0.30/share)Travis WhitfillBought 15,000 shares on 2/13/2024Total: $4,500.00 ($0.30/share)Norm StaskeyBought 3,300 shares on 2/13/2024Total: $990.00 ($0.30/share)Leslie W KreisBought 600,000 shares on 6/21/2023Total: $3 M ($5.00/share)View All Insider Transactions AZTR Stock Analysis - Frequently Asked Questions Are investors shorting Azitra? Azitra saw a increase in short interest in March. As of March 31st, there was short interest totaling 200,500 shares, an increase of 96.4% from the March 15th total of 102,100 shares. Based on an average daily trading volume, of 514,100 shares, the short-interest ratio is currently 0.4 days. Currently, 1.3% of the company's shares are short sold. View Azitra's Short Interest. How do I buy shares of Azitra? Shares of AZTR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NYSEAMERICAN:AZTR) was last updated on 5/9/2024 by MarketBeat.com Staff From Our PartnersTech GIANT’s Plans to Revolutionize Crypto…Crypto 101 MediaThe 2024 Gold Rush: Unleashing Market PotentialPriority GoldDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithDems have chosen Biden replacement?Paradigm Press348 million Americans lives to END as we know it?The Oxford ClubGold Set to EXPLODE!Gold Safe ExchangeObama’s Forever Term [exposed]Porter & Company Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Azitra, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
